TOKYO -- Fujifilm will partner with Takeda Pharmaceutical to develop and sell a regenerative medicine product for heart patients, the company announced Thursday.
The deal combines Fujifilm's manufacturing expertise with Takeda's experience in clinical tests and pharmaceutical sales. The product, which is being developed by Fujifilm's U.S. subsidiary Cellular Dynamics International, uses induced pluripotent stem cells.
